StellarGene Technologies is a company driven by Science and its applicability in Healthcare and Agriculture. We work in conjunction with Scientists, Clinicians and the Community bringing Genomic solutions to Research, Medicine and Lifestyle.
Lead by a Highly Experienced Team motivated by the Potential of Genomics, we carry the vision of offering
• Diagnostics that enable Decisions • Planning that leads to Publications • Trainings that lead to empowerment
We engage the latest technologies including Microarray and Next Generation Sequencing to deliver
• Quality • Insights • Actionability • Promptness • Growth
StellarGene aims to translate the power of Genomics in a language comprehensible for the common man.
With the motto of
Better Science Better Health
the company envisions a “from bench to bedside” approach achieved by
correct execution, better interpretations and association to actionability
Kapil Ravi is the Director of Business Strategies and Execution at StellarGene. He is an entrepreneur, business consultant and believes increative genius & hard work. He has substantial leadership experience at senior management positions, sales, marketing, and business development, distribution management, and international collaborations.
Kapil played a key role in collaborating, strategizing and establishing successful businesses for many brands in India like Affymetrix (Axiom Genotyping), Pacific Biosciences (SMRT Sequencing), Agilent Technologies (Genomic Division); Accuri (now a BD brand) and Caliper Life Sciences (now a Perkin Elmer Company). Prior to StellarGene, Kapil worked as Country Head for Genomics Division at Imperial Life Sciences (P) Ltd. Besides heading sales execution of more than 50 microarray workstations & over 80 microfluidic systems, Kapil successfully supervised the sales of the first two PacBio RSII (Single Molecule Real Time Sequencing) systems in India.
He has rich experience in high value tender business and proprietary sales strategies. He also worked with Millipore India (now Merck Millipore) in the Biosciences Division. Kapil has done his Master's in Biotechnology from Rai Foundation College; New Delhi (affiliated to MD University)
Aparna Sapra is a Molecular Geneticist and Cell Biologist. She has over 17 years of experience in Research beginning with her MS and PhD from Indian Institute of Science-Bangalore, following which she was a Marie-Curie Fellow at Max Plank Institute. Aparna has extensive industry experience in the genomics field, having worked in Drug Discovery at the Biomarker and Translational group at Piramal Lifesciences, in Personalized medicine for Oncology at Mir Lifescience and at BioXcel-Pharma Consultancy. Aparna has authored several scientific publications in international peer reviewed journals like Nature. Structural & Molecular Biology, Molecular Cell, Nucleic Acids Research.
At StellarGene, Aparna heads the Scientific Operations, Research & Development efforts for new Diagnostics, Critical interpretations and Collaborative projects.